Kim, M., Na, J. M., Lee, G., Lee, S. J., Kim, J. D., & Yang, J. W. (2021). EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy. J Pathol Transl Med.
Chicago Style CitationKim, Minhye, Ji Min Na, Gyeong-Won Lee, Seung Jun Lee, Jong Duk Kim, i Jung Wook Yang. "EGFR-mutated Pulmonary Adenocarcinoma With Concurrent PIK3CA Mutation, and With Acquired RET Fusion and EGFR T790M Mutation After Afatinib Therapy." J Pathol Transl Med 2021.
Cita MLAKim, Minhye, et al. "EGFR-mutated Pulmonary Adenocarcinoma With Concurrent PIK3CA Mutation, and With Acquired RET Fusion and EGFR T790M Mutation After Afatinib Therapy." J Pathol Transl Med 2021.
Atenció: Aquestes cites poden no estar 100% correctes.